MAPT and Alzheimer disease 18: In particular, previous studies have shown that grey matter atrophy and cortical Aβ burden relate to separable patterns of future cognitive decline46,47,50,51, and longitudinal changes in tau relate to cognitive decline in preclinical AD18.